Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Complete Genome Sequences of Three Multidrug-Resistant Clinical Isolates of Streptococcus pneumoniae Serotype 19A with Different Susceptibilities to the Myxobacterial Metabolite Carolacton.

Donner J, Bunk B, Schober I, Spröer C, Bergmann S, Jarek M, Overmann J, Wagner-Döbler I.

Genome Announc. 2017 Feb 16;5(7). pii: e01641-16. doi: 10.1128/genomeA.01641-16.

2.

The biofilm inhibitor Carolacton inhibits planktonic growth of virulent pneumococci via a conserved target.

Donner J, Reck M, Bergmann S, Kirschning A, Müller R, Wagner-Döbler I.

Sci Rep. 2016 Jul 11;6:29677. doi: 10.1038/srep29677.

3.

Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain.

Ardanuy C, Rolo D, Fenoll A, Tarrago D, Calatayud L, Liñares J.

J Antimicrob Chemother. 2009 Sep;64(3):507-10. doi: 10.1093/jac/dkp210. Epub 2009 Jun 17.

PMID:
19535383
4.

Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae and molecular characterization of multidrug-resistant serotype 19F, 6B, and 23F Pneumococci in northern Thailand.

Watanabe H, Asoh N, Hoshino K, Watanabe K, Oishi K, Kositsakulchai W, Sanchai T, Kunsuikmengrai K, Kahintapong S, Khantawa B, Tharavichitkul P, Sirisanthana T, Nagatake T.

J Clin Microbiol. 2003 Sep;41(9):4178-83.

5.

Dominance of multidrug-resistant Denmark(14)-32 (ST230) clone among Streptococcus pneumoniae serotype 19A isolates causing pneumococcal disease in Bulgaria from 1992 to 2013.

Setchanova LP, Alexandrova A, Dacheva D, Mitov I, Kaneva R, Mitev V.

Microb Drug Resist. 2015 Feb;21(1):35-42. doi: 10.1089/mdr.2014.0076. Epub 2014 Jul 31.

PMID:
25080213
6.

Molecular epidemiology of serotype 19A Streptococcus pneumoniae among invasive isolates from Alaska, 1986-2010.

Rudolph K, Bruce MG, Bulkow L, Zulz T, Reasonover A, Harker-Jones M, Hurlburt D, Hennessy TW.

Int J Circumpolar Health. 2013 Aug 5;72. doi: 10.3402/ijch.v72i0.20854. eCollection 2013.

7.

Whole Genome Sequencing of 39 Invasive Streptococcus pneumoniae Sequence Type 199 Isolates Revealed Switches from Serotype 19A to 15B.

Makarewicz O, Lucas M, Brandt C, Herrmann L, Albersmeier A, Rückert C, Blom J, Goesmann A, van der Linden M, Kalinowski J, Pletz MW.

PLoS One. 2017 Jan 3;12(1):e0169370. doi: 10.1371/journal.pone.0169370. eCollection 2017.

8.

Capsular serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing invasive pneumococcal disease from 2009-2012 with an emphasis on serotype 19A in bacteraemic pneumonia and empyema and β-lactam resistance.

Lee MR, Chen CM, Chuang TY, Huang YT, Hsueh PR.

Int J Antimicrob Agents. 2013 Nov;42(5):395-402. doi: 10.1016/j.ijantimicag.2013.07.017. Epub 2013 Sep 6.

PMID:
24071028
9.

Characterization of Streptococcus pneumoniae invasive serotype 19A isolates recovered in Colombia.

Ramos V, Parra EL, Duarte C, Moreno J.

Vaccine. 2014 Feb 7;32(7):755-8. doi: 10.1016/j.vaccine.2013.12.024. Epub 2013 Dec 25.

PMID:
24374499
11.

Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.

Moore MR, Gertz RE Jr, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH, Hadler JL, Bennett NM, Thomas AR, McGee L, Pilishvili T, Brueggemann AB, Whitney CG, Jorgensen JH, Beall B.

J Infect Dis. 2008 Apr 1;197(7):1016-27. doi: 10.1086/528996.

PMID:
18419539
13.
14.

Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.

Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG, Beall B; Active Bacterial Core Surveillance Team.

J Infect Dis. 2005 Dec 1;192(11):1988-95. Epub 2005 Nov 1.

PMID:
16267772
15.

Relationship between the original multiply resistant South African isolates of Streptococcus pneumoniae from 1977 to 1978 and contemporary international resistant clones.

Reinert RR, Jacobs MR, Appelbaum PC, Bajaksouzian S, Cordeiro S, van der Linden M, Al-Lahham A.

J Clin Microbiol. 2005 Dec;43(12):6035-41.

16.

Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates.

Ongkasuwan J, Valdez TA, Hulten KG, Mason EO Jr, Kaplan SL.

Pediatrics. 2008 Jul;122(1):34-9. doi: 10.1542/peds.2007-2703.

PMID:
18595984
17.

Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae.

Pillai DR, Shahinas D, Buzina A, Pollock RA, Lau R, Khairnar K, Wong A, Farrell DJ, Green K, McGeer A, Low DE.

BMC Genomics. 2009 Dec 30;10:642. doi: 10.1186/1471-2164-10-642.

18.

Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.

Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R.

J Antimicrob Chemother. 2009 Mar;63(3):511-9. doi: 10.1093/jac/dkn538. Epub 2009 Jan 27.

PMID:
19174454
19.

Prevalence of serotype and multidrug-resistance of Streptococcus pneumoniae respiratory tract isolates in 265 adults and 36 children in Korea, 2002-2005.

Lee S, Lee K, Kang Y, Bae S.

Microb Drug Resist. 2010 Jun;16(2):135-42. doi: 10.1089/mdr.2009.0114.

PMID:
20370508
20.

Supplemental Content

Support Center